Live tape
Top 8, mentions 7d10,172GOOGL1,959 mentions▲ +0.04SNDK1,581 mentions▲ +0.11MRNA1,216 mentions▲ +0.09NVDA1,213 mentions▲ +0.08META1,198 mentions▲ +0.03SPCX1,127 mentions▲ +0.09NBIS1,004 mentions▲ +0.09HTZ874 mentions▲ +0.09

Equity · Industrials

CBZ

CBIZ, Inc. · NYSE

$55 +0.60% 1D Finazon · prior-day close · Aug 18, 2026
Price · Chart
Our own end-of-day closes 61 sessions
$60 $20 21 May 18 Aug

The line runs $32.06 on 21 May through $55 on 18 August, on a scale from $20 to $60. Days the market did not trade hold the previous close, flat.

The chart above plots the price of CBZ over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 61 sessions over that window: $32.06 on 21 May 2026 through $55 on 18 August 2026.

Market cap $3.0B
P/E (TTM) 14.0
52-week range $25 – $67
Avg volume 287.0K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 19, 2026

CBZ insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 4 Aug 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 2

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
04 Aug 2026 SHERMAN A HAAG Director Option exercise 50,000 $1.23M
04 Aug 2026 SHERMAN A HAAG Director Tax withheld 22,354 $1.23M

CBZ reported financials

SEC EDGAR XBRL

CBZ reported revenue of $2.8B for the fiscal year ended 31 Dec 2025. Net income over the same period was $115.4M.

Figure Reported Period
Revenue $2.8B 31 Dec 2025 fiscal year
Net income $115.4M 31 Dec 2025 fiscal year
Diluted EPS $1.83 31 Dec 2025 fiscal year
Total assets $4.6B 30 Jun 2026 at period end
Total equity $1.9B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

CBZ earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.31
31 Mar 2026 Q2 2026 $2.49
31 Dec 2025 FY 2025 $1.83
30 Sep 2025 Q3 2025 $0.48
30 Jun 2025 Q2 2025 $0.66
31 Mar 2025 Q1 2025 $1.91
31 Dec 2024 FY 2024 $0.78
30 Sep 2024 Q3 2024 $0.70

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

CBZ institutional holders

SEC Form 13F

8 of the 45 institutional funds we track reported a CBZ position for the quarter ended 30 Jun 2026 — a combined $42.7M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
AQR Capital Management Added +188.7% shares 709,617 $22.8M
Tudor Investment Corp Added +36.2% shares 213,627 $6.9M
Two Sigma Investments Trimmed −58.1% shares 138,434 $4.4M
D. E. Shaw & Co. Trimmed −58.2% shares 112,199 $3.6M
Marshall Wace Added +271.5% shares 74,383 $2.4M
Balyasny Asset Management Trimmed −31.1% shares 37,832 $1.2M
Citadel Advisors Trimmed −67.0% shares 34,235 $1.1M
Bridgewater Associates New position 11,093 $356K

Source: SEC EDGAR 13F filings

CBZ fails-to-deliver

SEC CNS data

On 31 Jul 2026, 55,965 shares of CBZ failed to deliver (about $3.1M) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
31 Jul 2026 55,965 $3.1M 0.103%
30 Jul 2026 116,706 $6.4M 0.215%
24 Jul 2026 125 $5K <0.001%
22 Jul 2026 28 $1K <0.001%
20 Jul 2026 7,362 $312K 0.014%
17 Jul 2026 5 $215 <0.001%
14 Jul 2026 68 $3K <0.001%
10 Jul 2026 23 $847 <0.001%
06 Jul 2026 4 $140 <0.001%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in CBZ

STOCK Act disclosures

The most recent congressional trade disclosed in CBZ is a purchase by Josh Gottheimer (house, NJ), dated 06 Apr 2026.

Date Member Type Amount
06 Apr 2026 filed 19 May 2026 Josh Gottheimer house · Democrat–NJ Purchase $1K–$15K

Source: U.S. House of Representatives financial disclosures